Pathophysiology of age-related macular degeneration: implications for treatment

J Garcia-Garcia, R Usategui-Martin, MR Sanabria… - Ophthalmic …, 2022 - karger.com
Age-related macular degeneration (AMD) is a complex, multifactorial, progressive retinal
disease that affects millions of people worldwide and has become the leading cause of …

[PDF][PDF] Age-related macular degeneration (AMD): pathogenesis and therapy

JZ Nowak - Pharmacological reports, 2006 - Citeseer
Age-related macular degeneration (AMD) is a disease leading to severe visual loss and
legal blindness in the elderly population. Its pathogenesis, likely multifactorial, involving a …

Age-related macular degeneration revisited–piecing the puzzle: the LXIX Edward Jackson memorial lecture

JW Miller - American journal of ophthalmology, 2013 - Elsevier
PURPOSE: To present the current understanding of age-related macular degeneration
(AMD) pathogenesis, based on clinical evidence, epidemiologic data, histopathologic …

Current concepts in the pathogenesis of age-related macular degeneration

MA Zarbin - Archives of ophthalmology, 2004 - jamanetwork.com
Objective To review and synthesize information concerning the pathogenesis ofage-related
macular degeneration (AMD). Methods Review of the English-language literature. Results …

Age-related macular degeneration

M Fleckenstein, TDL Keenan, RH Guymer… - Nature reviews Disease …, 2021 - nature.com
Age-related macular degeneration (AMD) is the leading cause of legal blindness in the
industrialized world. AMD is characterized by accumulation of extracellular deposits, namely …

Mechanisms of age‐related macular degeneration and therapeutic opportunities

M van Lookeren Campagne, J LeCouter… - The Journal of …, 2014 - Wiley Online Library
As the age of the population increases in many nations, age‐related degenerative diseases
pose significant socioeconomic challenges. One of the key degenerative diseases that …

Age‐related macular degeneration: new paradigms for treatment and management of AMD

LF Hernández-Zimbrón… - Oxidative medicine …, 2018 - Wiley Online Library
Age‐related macular degeneration (AMD) is a well‐characterized and extensively studied
disease. It is currently considered the leading cause of visual disability among patients over …

Age‐related macular degeneration

LK Cheung, A Eaton - Pharmacotherapy: The Journal of Human …, 2013 - Wiley Online Library
Age‐related macular degeneration (AMD) is the leading cause of blindness in the elderly,
and the prevalence of the disease increases exponentially with every decade after age 50 …

Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

KM Gehrs, DH Anderson, LV Johnson… - Annals of …, 2006 - Taylor & Francis
Today, the average life expectancy in developed nations is over 80 years and climbing. And
yet, the quality of life during those additional years is often significantly diminished by the …

[HTML][HTML] Age-related macular degeneration: advances in management and diagnosis

Y Yonekawa, JW Miller, IK Kim - Journal of clinical medicine, 2015 - mdpi.com
Age-related macular degeneration (AMD) is the most common cause of irreversible visual
impairment in older populations in industrialized nations. AMD is a late-onset deterioration …